Bio & Pharma
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
Aug 10, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience buys 6.5 million Novavax shares for $83.4 million
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...
Aug 09, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
SK Pharmteco secures 12 global pharma clients, sets up US R&D center
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured 12 global pharm...
Aug 09, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Kakao Healthcare signs agreement with Novo Nordisk for digital service
Kakao Healthcare Corp., a digital healthcare platform unit of South Korea's Kakao Corp., announced that it has signed on Tuesday a business agreemen...
Aug 08, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Dongwha Pharm to buy Vietnamese pharmacy chain at $30 mn
South Korea's Dongwha Pharm announced on Thursday that it signed an agreement to acquire a 51% stake in Trung Son Pharma, a leading pharmacy chain i...
Aug 04, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Biopharmaceuticals forms Scientific Advisory Board
South Korea's SK Biopharmaceuticals assembled its Scientific Advisory Board (SAB) composed of world-renowned physicians and drug development experts...
Aug 03, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
LabGenomics plans to buy 4 to 5 more CLIA labs in US by 2027
LabGenomics Co. will advance into the US diagnostics market with laboratories regulated by the country’s Clinical Laboratory Improvement Amend...
Aug 02, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Samsung Bioepis seeks to buy Biogen biosimilar unit
Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea’s Samsung Group, seeks to buy a biosimilar business d...
Aug 02, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Daewoong launches GERD treatment Fexuclu in Philippines
South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...
Aug 01, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
LG Chem to make first domestic 6-in-1 vaccine for infants
South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...
Aug 01, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
IMM PE seeks to sell Korean contract drugmaker at $784 mn
IMM Private Equity has put a South Korean contract drugmaker on the market for up to 1 trillion won ($784 million) in a deal likely to attract major...
Jul 31, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Gencurix joins US gov't Cancer Moonshot project
South Korean cancer molecular diagnostics company Gencurix Inc. announced on Monday that it joins US President Joe Biden's cancer-conquering project...
Jul 31, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Bertis Pan-omics Analysis Solution, Systems (PASS) launched in US
Bertis, a company specializing in the development of proteomics-based precision medicine technology , announced on Monday the launch of PASS (Pan-om...
Jul 31, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
CJ Bioscience to launch microbiome analysis service in 2024
South Korea's CJ Bioscience Inc. announced on Friday that it plans to officially launch the microbe analysis platform "EzBiome Bioinformatics app" (...
Jul 28, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Boryung Pharma's sales surpass $311 mn in H1 2023
South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...
Jul 28, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
S.Korea’s aid service Boram Group enters companion animal market
South Korea’s Boram Group, whose main affiliate is an aid company, has entered the companion animal market. Affiliates Boram Sangjo and ...
Jul 28, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Kolon Pharma, Dongbang Medical to export medical threads to Brazil
Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, announced on Thursday that it has signed a business agreement with Dongbang...
Jul 27, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Raphas microneedle passes US FDA's cGMP inspection
South Korea's microneedle maker Raphas Co. announced on Wednesday that it has passed the Current Good Manufacturing Practice (cGMP) inspection by ...
Jul 26, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Huons’ overseas market expansion leads to record-high sales
South Korea's Huons Group is continuing its record-breaking performance while expanding its influence in the global market.According to Huons Group ...
Jul 25, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Kwangdong to sell exclusively three global rare disease drugs
South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it signed an agreement for securing exclusive sales and distri...
Jul 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
S.Korea's NGeneBio establishes US corporation NGeneBioAI
South Korean medical diagnostic company NGeneBio Co. announced on Monday that it has established an artificial intelligence (AI) precision diagnosti...
Jul 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
NKMax to supply health functional food to Chinese company
South Korean natural killer cell drug maker NKMax Co. announced in a regulatory filing on Friday that it has signed a supply contract with China's S...
Jul 21, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Clinomics releases equipment that quickly finds lung cancer mutations
Clinomics, a South Korean biotech company specializing in liquid biopsies, on Thursday said it developed equipment that can detect four types of l...
Jul 21, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Chemicals to supply diabetes drugs to AstraZeneca Korea
SK Chemicals Co., a South Korean chemicals maker and drug developer, said on Thursday it has signed a contract to supply diabetes medications to glo...
Jul 20, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
GC Biopharma wins approval for quadrivalent flu vaccine in Egypt
South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...
Jul 19, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Novomics expands presence in Chinese cancer market
South Korean molecular diagnostics company Novomics Co. announced on Wednesday that it has signed a collaboration agreement with Chinese molecular d...
Jul 19, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Biopharm eyes Asia's No.1 spot in radioactive drug market
South Korea’s SK Biopharmaceuticals Co. is aiming to triple its enterprise value to $15 billion by 2026 with the goal of rising to the top run...
Jul 19, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Prestige Biopharma participates in US gov’t Cancer Moonshot
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, announced on Tuesday that it will partici...
Jul 18, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Corentec enters Japanese artificial joint market
Corentec Co., a South Korean company that develops artificial joints and spinal implants, is making a full-fledged entry into the Japanese market. T...
Jul 18, 2023 (Gmt+09:00)
1 Min read
Latest News
- 1 BMW Surpasses Mercedes in Sales – Imported Car Market 'Shake-Up'
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google